Ranolazine

Product NDC
0904-7506
11-digit product format
009047506
Labeler code
0904
Product ID
0904-7506_655f85d1-ebab-4b44-8619-2a54b34724a9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Ranolazine
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
Major Pharmaceuticals
Application
ANDA209953
Marketing category
ANDA
Marketing start
2025-01-17
Substance
RANOLAZINE
Active strength
500 mg/1
Pharmacologic classes
Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Related Records

Related UNII Ingredients

UNIIPreferred termRegistry numberMatched term
A6IEZ5M406RANOLAZINE95635-55-5RANOLAZINE

Packages

Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0904-7506-040090475060430 BLISTER PACK in 1 CARTON (0904-7506-04) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK30 blister pack2025-01-17NoNoHistorical

Related DailyMed Labels

TitleManufacturerEffective dateTypeVersion
RanolazineMajor Pharmaceuticals2025-12-29HUMAN PRESCRIPTION DRUG LABEL2